TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Odeum Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
21
|
23 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
-45
|
-34 | |
| EBITDA |
-38
|
-28 | |
| Total assets |
1,376
|
1,503 | |
| Current assets |
1,011
|
1,125 | |
| Current liabilities |
38
|
93 | |
| Equity capital |
1,318
|
1,379 | |
| - share capital |
10
|
10 | |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
95.8%
|
91.7% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-214.3%
|
-147.8% | |
| Return on assets (ROA) |
-3.3%
|
-2.3% | |
| Current ratio |
2660.5%
|
1209.7% | |
| Return on equity (ROE) |
-3.4%
|
-2.5% | |
| Change turnover |
-2
|
8 | |
| Change turnover % |
9%
|
-7%
|
57% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.